No label defined (Q26862017)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	No label defined	scientific article

Statements

scholarly article

1 reference

psoriatic arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Philip J. Mease

1

1 reference

language of work or name

1 reference

publication date

November 2011

1 reference

Arthritis Care and Research

1 reference

63 Suppl 11

1 reference

S11

0 references

S64-85

1 reference

Improving the routine management of rheumatoid arthritis: the value of tight control

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Evidence for treating rheumatoid arthritis to target: results of a systematic literature search

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Treating rheumatoid arthritis to target: recommendations of an international task force

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Psoriatic arthritis: update on pathophysiology, assessment and management

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Managing comorbid disease in patients with psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Psoriatic arthritis treatment: biological response modifiers

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Psoriatic arthritis: pharmacotherapy update

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Psoriatic arthritis assessment tools in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Assessment of patients with psoriatic arthritis: a review of currently available measures

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Measuring joint involvement in polyarticular psoriatic arthritis: an introduction of alternatives.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

The self-administered psoriasis area and severity index is valid and reliable

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

The concept of a "synovio-entheseal complex" and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Assessment of enthesitis in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Disease measurement--enthesitis, skin, nails, spine and dactylitis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Could the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis?

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Measurement of patient outcome in arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

A longitudinal study of the effect of disease activity and clinical damage on physical function over the course of psoriatic arthritis: Does the effect change over time?

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Minimally important difference for patient-reported outcomes in psoriatic arthritis: Health Assessment Questionnaire and pain, fatigue, and global visual analog scales.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Dermatology in-patient management greatly improves life quality.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Treatment recommendations for psoriatic arthritis.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Patient perspective on outcomes in rheumatology -- a position paper for OMERACT 9.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Fatigue in cancer patients compared with fatigue in the general United States population.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS).

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Psoriatic arthritis imaging: a review of scoring methods

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Psoriatic arthritis spondylitis radiology index: a modified index for radiologic assessment of axial involvement in psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Clinical utility of ultrasonography in spondyloarthropathies

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

The role of ultrasound in the diagnosis and management of psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Evaluation of several ultrasonography scoring systems for synovitis and comparison to clinical examination: results from a prospective multicentre study of rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Informing response criteria for psoriatic arthritis. I: discrimination models based on data from 3 anti-tumor necrosis factor randomized studies

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Development of a preliminary composite disease activity index in psoriatic arthritis.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Remission in psoriatic arthritis: is it possible and how can it be predicted?

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Evaluation of ankylosing spondylitis spinal mobility measurements in the assessment of spinal involvement in psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20577

21 January 2018

Identifiers

10.1002/ACR.20577

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26862017&oldid=1963923591"